Scholarlink

Background <p>Breast cancer remains a leading cause of morbidity and mortality among women worldwide. According to the recent statistics by World Health Organization (WHO), it is the leading cause of death from cancer in women worldwide and it is the most frequently diagnosed cancer. This meta-analysis aims to systematically evaluate the efficacy and safety of S-ketamine in patients undergoing modified radical mastectomy.</p> Method <p>We searched five databases; PubMed, Scopus, Science Direct, Web of Science, and Medline Plus. We included six studies. The applicable outcomes for meta-analysis about efficacy and safety of S-ketamine in patients undergoing modified radical mastectomy.</p> Results <p>Six RCTs included in our meta-analysis found that Esketamine group had a statistically significant lower VAS score after 4 h, after 6 h, after 24 h, after 48 h; (MD = −1.54; 95% CI [−1.65, −1.42], <i>P</i> &lt; 0.00001), (MD = −0.55; 95% CI [−0.66, −0.45], <i>P</i> &lt; 0.00001), (MD = −0.75; 95% CI [−0.84, −0.66], <i>P</i> &lt; 0.00001,), (MD = −0.26; 95% CI [−0.48, −0.03], <i>P</i> = 0.03) <i>P</i> &lt; 0.00001), respectively.</p> Conclusion <p>We conclude that S-ketamine is valuable for reducing pain and safe in patients undergoing modified radical mastectomy.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Efficacy and safety of S-ketamine in pain management for breast cancer patients undergoing modified radical mastectomy: a meta-analysis of randomized controlled trials

  • 期刊论文

  • 发表日期：

    2025年2月5日

查看全文
  • Bilal Abu-Hussein,
  • Amr Elrosasy,
  • Haidy Samy,
  • Ahmed Said Ali,
  • Said Samir Alijla,
  • Ahmad Naoras Bitar,
  • Ibrahim Gamal

摘要

Background

Breast cancer remains a leading cause of morbidity and mortality among women worldwide. According to the recent statistics by World Health Organization (WHO), it is the leading cause of death from cancer in women worldwide and it is the most frequently diagnosed cancer. This meta-analysis aims to systematically evaluate the efficacy and safety of S-ketamine in patients undergoing modified radical mastectomy.

Method

We searched five databases; PubMed, Scopus, Science Direct, Web of Science, and Medline Plus. We included six studies. The applicable outcomes for meta-analysis about efficacy and safety of S-ketamine in patients undergoing modified radical mastectomy.

Results

Six RCTs included in our meta-analysis found that Esketamine group had a statistically significant lower VAS score after 4 h, after 6 h, after 24 h, after 48 h; (MD = −1.54; 95% CI [−1.65, −1.42], P < 0.00001), (MD = −0.55; 95% CI [−0.66, −0.45], P < 0.00001), (MD = −0.75; 95% CI [−0.84, −0.66], P < 0.00001,), (MD = −0.26; 95% CI [−0.48, −0.03], P = 0.03) P < 0.00001), respectively.

Conclusion

We conclude that S-ketamine is valuable for reducing pain and safe in patients undergoing modified radical mastectomy.